Can a smartphone app boost sexual health after a stem cell transplant?

NCT ID NCT06541002

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new digital application called SHIFT to see if it can improve sexual health, quality of life, and reduce distress in people who have had a stem cell or bone marrow transplant. The trial will enroll 300 adult survivors who are at least three months post-transplant and have sexual health concerns. Participants will either use the SHIFT app over 8 weeks or receive enhanced usual care, which includes a medical check-up and possible medications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
digital application (SHIFT) with behavioral modules and clinician consultation
What this could lead to
If it works, this could provide a convenient, self-paced digital tool to help stem cell transplant survivors improve their sexual health and quality of life.
What could go wrong
This is a relatively small, early-stage trial testing a behavioral intervention, so results may not apply to all survivors. The app is only available in English and Spanish, which limits who can use it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE MARROW TRANSPLANT COMPLICATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fox Chase Cancer Center

    NOT_YET_RECRUITING

    Philadelphia, Pennsylvania, 19111, United States

  • Massachusetts General Hospital (MGH)

    RECRUITING

    Boston, Massachusetts, 02114, United States

  • University of Miami

    NOT_YET_RECRUITING

    Coral Gables, Florida, 33124, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.